Beiersdorf Aktiengesellschaft BEI.DE
Composite 57/100; the shares have moved about 25% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Momentum ranks 32/100 — a moderate mark against it.
Balance-sheet strength ranks 88/100 — a strong point in its favour. Quality ranks 64/100 — a moderate point in its favour. Valuation ranks 57/100 — a slight point in its favour.
Momentum ranks 32/100 — a moderate mark against it. Growth ranks 32/100 — a moderate mark against it.
What the company does Beiersdorf AG (BEI.DE) is a German consumer goods company with two segments: Consumer Business (skin/body care under brands like NIVEA and Eucerin) and Tesa Business (adhesive solutions for industries and consumers). It operates globally, leveraging a portfolio of 15+ brands and an online store.
Key financials Key metrics include ROE 11.2%, ROA 6.6%, and ROCE 24.2%. Margins are strong: gross 57.7%, operating 11.2%, net 9.5%. Revenue growth is flat at -0.2%, but EPS grew 19.6%. Debt/Equity is low at 0.03, with solid interest coverage of 32.73 and current ratio of 1.90.
Stock health Sideravia scores show average quality (56.7/100), with strong Strength (88.8) and Valuation (50.6) but weak Growth (34.4) and Momentum (34.1). Profitability is solid (Piotroski 6/9, Altman Z 5.69), though FCF yield is modest at 2.1%.
Price vs fair value The stock trades at a **PREMIUM of 42.70%** versus our fair-value estimate and a **discount of 6.87%** versus the analyst 12-month target. - Valuation percentile 50.6/100 suggests fair value (Sideravia). - Forward P/E 18.08 and PEG 6.24 indicate moderate earnings expectations (Valuation). - Weak momentum: -25.12% over 12 months and RSI 62.70 (Momentum). - Analyst target 86.05 implies 6.87% upside (Analyst count 19.0).
Looking forward Flat revenue growth (-0.2%) and weak momentum (-25.12% over 12 months) may explain the premium to fair value, despite strong profitability and low leverage. Analysts see potential upside to 86.05, suggesting a balanced risk/reward if growth stabilizes.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-05, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.